arrow
T

Thomas Gasser

german center for neurodegenerative diseases
H指数:137
被引数:8.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of Genetic Variants in the Longevity Gene PPARGC1A and Cerebrospinal Fluid PPARγ Levels on Clinical Trajectories in Parkinson’s Disease: Potential Biomarkers for Neurodegeneration and Ageing

长寿基因PPARGC1A的遗传变异和脑脊液PPARγ水平对帕金森病临床轨迹的影响:神经退行性疾病和衰老的潜在生物标志物

2026-06-090
PRE
The PET tracer [11C]MODAG-005 targets alpha-synuclein aggregates in the brain

PET示踪剂[11C]MODAG-005靶向大脑中的α-突触核蛋白聚集物

2026-05-270
PRE
Quantification of cerebrospinal fluid α-synuclein seeds by endpoint dilution seed amplification assay in Parkinson’s disease

帕金森病中通过终点稀释种子扩增试验对脑脊液α-突触核蛋白种子的定量分析

2025-12-010
OAAI
Chr:17q21.31 locus risk haplotype H1 susceptibility to ferroptosis is mediated by endolysosomal pathway

17q21.31位点的风险单倍型H1对铁死亡易感性的介导作用是通过内体-溶酶体途径实现的。

2025-11-130
OAAI
Genome-wide association study of REM sleep behavior disorder in Parkinson’s disease

帕金森病中快速眼动睡眠行为障碍的全基因组关联研究

2025-09-250
OAAI
Progression to Parkinson's dementia is not modulated by genetic risk variants for Alzheimer's or Parkinson's disease

帕金森痴呆的进展不受阿尔茨海默病或帕金森病的遗传风险变异的调节。

2025-07-300
OA
Genetic Risk Factors in Isolated Dystonia Escape Genome-Wide Association Studies
2024-09-170
OA
Association of Body Mass Index and Parkinson Disease A Bidirectional Mendelian Randomization Study

体重指数与帕金森病的关系 -- 双向孟德尔随机化研究

2024-08-131
PRE
Team Science Approaches to Unravel Monogenic Parkinson's Disease on a Global Scale
2024-07-301
OA
Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS

血浆细胞外囊泡tau和TDP-43作为FTD和ALS的诊断生物标志物

2024-06-1812
OAAI